home / stock / aezs:cc / aezs:cc quote
Last: | $5.92 |
---|---|
Change Percent: | 3.14% |
Open: | $5.74 |
Close: | $5.74 |
High: | $5.92 |
Low: | $5.74 |
Volume: | 3,665 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.92 | $5.74 | $5.74 | $5.92 | $5.74 | 3,665 | 08-02-2022 |
$0.365 | $0.39 | $0.365 | $0.39 | $0.36 | 76,922 | 05-06-2022 |
$0.38 | $0.39 | $0.38 | $0.39 | $0.37 | 39,748 | 05-05-2022 |
$0.39 | $0.395 | $0.39 | $0.395 | $0.38 | 9,995 | 05-04-2022 |
$0.39 | $0.39 | $0.39 | $0.4 | $0.39 | 21,050 | 05-03-2022 |
$0.39 | $0.39 | $0.39 | $0.39 | $0.375 | 18,590 | 05-02-2022 |
$0.38 | $0.39 | $0.38 | $0.395 | $0.38 | 25,491 | 04-29-2022 |
$0.385 | $0.375 | $0.385 | $0.39 | $0.37 | 48,891 | 04-28-2022 |
$0.37 | $0.39 | $0.37 | $0.39 | $0.37 | 79,036 | 04-27-2022 |
$0.39 | $0.4 | $0.39 | $0.405 | $0.385 | 79,150 | 04-26-2022 |
$0.4 | $0.39 | $0.4 | $0.415 | $0.375 | 303,866 | 04-25-2022 |
$0.395 | $0.395 | $0.395 | $0.405 | $0.38 | 112,608 | 04-22-2022 |
$0.4 | $0.41 | $0.4 | $0.41 | $0.385 | 95,732 | 04-21-2022 |
$0.41 | $0.405 | $0.41 | $0.415 | $0.4 | 23,518 | 04-20-2022 |
$0.415 | $0.41 | $0.415 | $0.42 | $0.395 | 83,295 | 04-19-2022 |
$0.41 | $0.425 | $0.41 | $0.425 | $0.39 | 192,251 | 04-18-2022 |
$0.415 | $0.43 | $0.415 | $0.43 | $0.415 | 280,939 | 04-15-2022 |
$0.415 | $0.43 | $0.415 | $0.43 | $0.415 | 279,423 | 04-14-2022 |
$0.445 | $0.44 | $0.445 | $0.445 | $0.425 | 103,487 | 04-13-2022 |
$0.44 | $0.435 | $0.44 | $0.45 | $0.435 | 38,595 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Aeterna Zentaris Inc. Company Name:
AEZS:CC Stock Symbol:
TSXC Market:
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into 2025 - All-stock merger of equals transaction with Ceapro, Inc. expected to close i...
TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that securityholders of both biopharmaceutical devel...